In our experiments, we reported for the first time that SLE patients’ serum concentration of the lncRNA CASC2 was significantly higher than those of healthy controls, with the highest values detected in LN patients versus the non-LN group (P < 0.001). This evidence concerns the gene CASC2 and lobular neoplasia.